Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brainfunctions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

Biotechnology

Therapeutics

Embera NeuroTherapeutics

Bob Linke

Ross Barrett

Lawrence Yarmaloff

Ann Robbins

Julie Ann Straub

Gary Connor

Bruce McCarthy

Advisory and Science Team

Leadership Team

��

Teams at Embera NeuroTherapeutics

Advisory and Science Team

Leadership Team

��������

Teams at Embera NeuroTherapeutics

Advisory and Science Team

Leadership Team

��